Literature DB >> 26383769

Polio elimination in Nigeria: A review.

Usman Nakakana Nasir1,2, Ananda Sankar Bandyopadhyay3, Francesca Montagnani4, Jacqueline Elaine Akite2, Etaluka Blanche Mungu2, Ifeanyi Valentine Uche2,5, Ahmed Mohammed Ismaila6.   

Abstract

Nigeria has made tremendous strides towards eliminating polio and has been free of wild polio virus (WPV) for more than a year as of August 2015. However, sustained focus towards getting rid of all types of poliovirus by improving population immunity and enhancing disease surveillance will be needed to ensure it sustains the polio-free status. We reviewed the pertinent literature including published and unpublished, official reports and working documents of the Global Polio Eradication Initiative (GPEI) partners as well as other concerned organizations. The literature were selected based on the following criteria: published in English Language, published after year 2000, relevant content and conformance to the theme of the review and these were sorted accordingly. The challenges facing the Polio Eradication Initiative (PEI) in Nigeria were found to fall into 3 broad categories viz failure to vaccinate, failure of the Oral Polio Vaccine (OPV) and epidemiology of the virus. Failure to vaccinate resulted from insecurity, heterogeneous political support, programmatic limitation in implementation of vaccination campaigns, poor performance of vaccination teams in persistently poor performing Local Government areas and sporadic vaccine refusals in Northern Nigeria. Sub optimal effectiveness of OPV in some settings as well as the rare occurrence of VDPVs associated with OPV type 2 in areas of low immunization coverage were also found to be key issues. Some of the innovations which helped to manage the threats to the PEI include a strong government accountability frame work, change from type 2 containing OPV to bi valent OPVs for supplementary immunization activities (SIA), enhancing environmental surveillance in key states (Sokoto, Kano and Borno) along with an overall improvement in SIA quality. There has been an improvement in coverage of routine immunization and vaccination campaigns, which has resulted in Nigeria being removed from the list of endemic countries following an absence of new cases for an entire year as of September 2015. However, the last mile remains to be crossed and there is need to further improve and sustain the momentum to complete the journey toward polio elimination.

Entities:  

Keywords:  Endemic polio; Nigeria; Polio eradication; supplementary immunisation activities; vaccine refusal

Mesh:

Substances:

Year:  2016        PMID: 26383769      PMCID: PMC4964709          DOI: 10.1080/21645515.2015.1088617

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  26 in total

1.  Outbreaks following wild poliovirus importations --- Europe, Africa, and Asia, January 2009-September 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-11-05       Impact factor: 17.586

2.  A vision of a world without polio: the OPV cessation strategy.

Authors:  David L Heymann; Roland W Sutter; R Bruce Aylward
Journal:  Biologicals       Date:  2006-05-08       Impact factor: 1.856

3.  Infectious disease. Vaccine-related polio outbreak in Nigeria raises concerns.

Authors:  Leslie Roberts
Journal:  Science       Date:  2007-09-28       Impact factor: 47.728

4.  How vaccine safety can become political--the example of polio in Nigeria.

Authors:  Christopher J Clements; Paul Greenough; Diana Shull
Journal:  Curr Drug Saf       Date:  2006-01

5.  Enhancing access to immunization services and exploiting the benefits of recent innovations in the African region.

Authors:  J C Okeibunor; B D Akanmori; G M Balcha; R Mihigo; R M Vaz; D Nshimirimana
Journal:  Vaccine       Date:  2013-06-22       Impact factor: 3.641

6.  OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.

Authors:  Alexandre Manirakiza; Emmanuella Picard; Richard Ngbale; Didier Menard; Ionela Gouandjika-Vasilache
Journal:  BMC Res Notes       Date:  2010-05-18

7.  Progress towards poliomyelitis eradication in Nigeria, January 2012-September 2013.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-12-20

8.  Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication.

Authors:  P Más Lago; V M Cáceres; M A Galindo; H E Gary; M Valcarcel; J Barrios; L Sarmiento; I Avalos; J A Bravo; R Palomera; M Bello; R W Sutter; M A Pallansch; C A de Quadros
Journal:  Int J Epidemiol       Date:  2001-10       Impact factor: 7.196

9.  Perspectives on polio and immunization in Northern Nigeria.

Authors:  Elisha Renne
Journal:  Soc Sci Med       Date:  2006-06-12       Impact factor: 4.634

10.  Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.

Authors:  F J Giwa; A T Olayinka; F T Ogunshola
Journal:  Vaccine       Date:  2012-09-20       Impact factor: 3.641

View more
  11 in total

1.  Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.

Authors:  Jingjun Qiu; Yunkai Yang; Lirong Huang; Ling Wang; Zhiwei Jiang; Jian Gong; Wei Wang; Hongyan Wang; Shaohong Guo; Chanjuan Li; Shuyuan Wei; Zhaojun Mo; Jielai Xia
Journal:  Hum Vaccin Immunother       Date:  2017-03-01       Impact factor: 3.452

2.  How service delivery implementation strategies can contribute to attaining universal health coverage: lessons from polio eradication using an implementation science approach.

Authors:  Adetoun Olateju; Michael A Peters; Ikponmwosa Osaghae; Olakunle Alonge
Journal:  BMC Public Health       Date:  2022-06-30       Impact factor: 4.135

3.  Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.

Authors:  Shelina Moonsamy; Melinda Suchard; Shabir A Madhi
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

4.  Public Knowledge and Opinion on Childhood Routine Immunizations in Two Major Cities of Anambra State, Nigeria.

Authors:  Angus Nnamdi Oli; Uchenna Chukwunonso Ogwaluonye; Chinyere Ukamaka Onubogu; Abraham Faith Ozumba; Obinna Henry Agbaenyi; Kenneth Nchekwube Okeke; Stanley Kenechukwu Onah; Jude C Okoro; Christian Chukwuemeka Ifezulike; George O Emechebe
Journal:  J Multidiscip Healthc       Date:  2021-02-02

5.  Common mental disorders in mothers of children attending out-patient malnutrition clinics in rural North-western Nigeria: a cross-sectional study.

Authors:  Aminu T Abdullahi; Zubaida L Farouk; Abdulazeez Imam
Journal:  BMC Public Health       Date:  2021-01-21       Impact factor: 3.295

6.  Factors associated with routine vaccination card retention among children aged 0-59 months in Yaounde-Cameroon: A cross-sectional survey.

Authors:  Martin Ndinakie Yakum; Atanga D Funwie; Atem Bethel Ajong; Marcellin Tsafack; Linda Evans Eba Ze; Ekome Serge Raoul Ekukole; Zahir Shah
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

7.  Eradication of wild poliovirus in Nigeria: Lessons learnt.

Authors:  Osmond C Ekwebelem; Obinna V Nnorom-Dike; Abdullahi Tunde Aborode; Nicholas C Ekwebelem; Job C Aleke; Ekenedirichukwu S Ofielu
Journal:  Public Health Pract (Oxf)       Date:  2021-05-15

8.  Exploring the influence of health management processes on health outcomes among internally displaced persons (IDPs).

Authors:  Winifred Ekezie; Penelope Siebert; Stephen Timmons; Rachael L Murray; Manpreet Bains
Journal:  J Migr Health       Date:  2022-06-22

9.  Last fight of wild polio in Africa: Nigeria's battle.

Authors:  Yusuff Adebayo Adebisi; Don Eliseo-Lucero Prisno; Boyiga Bodinga Nuga
Journal:  Public Health Pract (Oxf)       Date:  2020-12-22

Review 10.  Lessons from the elimination of poliomyelitis in Africa.

Authors:  Abdulaziz Mohammed; Oyewale Tomori; John N Nkengasong
Journal:  Nat Rev Immunol       Date:  2021-10-25       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.